Dagmar S. Lang
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers.
Journal: Cancer biology & medicine
Published: September 14, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 13, 2019
SNW1 is a prognostic biomarker in prostate cancer.
Journal: Diagnostic pathology
Published: December 07, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
Journal: Scientific reports
Published: August 22, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer types.
Journal: Oncology letters
Published: January 04, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
Journal: Oncology letters
Published: September 21, 2017
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
Journal: BMC cancer
Published: June 16, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Journal: Neoplasia (New York, N.Y.)
Published: March 21, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
Journal: International journal of molecular sciences
Published: January 05, 2017
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
Journal: Scientific reports
Published: January 04, 2017
Last Updated: 09/26/2026